Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ThyroVive is a multi-ingredient nutraceutical supplement developed by Delfran Pharmaceuticals, a South African company specializing in fertility and female healthcare. It is formulated with 17 essential vitamins and minerals, including iodine, selenium, zinc, and the amino acid L-tyrosine, to support normal thyroid function and the production of thyroid hormones. The supplement provides critical substrates like iodine for hormone synthesis and selenium for the peripheral conversion of thyroxine (T4) to the more active triiodothyronine (T3). It is intended for individuals seeking supportive care for thyroid health and is available as oral vegetable capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ThyroVive.